Breaking News
November 14, 2018 - Appendix removal is linked to lower risk of Parkinson’s
November 14, 2018 - Lifting weights for less than an hour a week may reduce cardiovascular disease risk
November 14, 2018 - Pulmonary rehabilitation rarely received by hospitalized COPD patients despite health benefits
November 14, 2018 - New anti-HER2 drug shows promising anti-tumor activity in gullet, stomach and bowel cancers
November 14, 2018 - Brigham investigators examine opioid use among Massachusetts adolescents, prescription trends
November 14, 2018 - Study defines biomarker in response to treatment of castration-resistant prostate cancer
November 14, 2018 - Study identifies potential therapeutic strategy for patients with clear cell renal cancer
November 14, 2018 - Bausch Health Announces U.S. Launch of Bryhali (halobetasol propionate) Lotion, 0.01%, for Plaque Psoriasis In Adults
November 14, 2018 - Alpha Fetoprotein (AFP) Tumor Marker Test: MedlinePlus Lab Test Information
November 14, 2018 - Researchers evaluate controversial treatment for Parkinson’s disease psychosis
November 14, 2018 - AI could help veterinarians code their notes
November 14, 2018 - Pre-schoolers with autism thrive in mainstream classroom settings
November 14, 2018 - Individual and work-related factors may help promote hospital physician engagement, finds study
November 14, 2018 - Complementary and alternative medicine is widely used by general population in England
November 14, 2018 - Study reveals link between tobacco availability and smoking during pregnancy
November 14, 2018 - Purdue researchers develop translucent base for silicon patches to deliver exact doses of biomolecules
November 14, 2018 - New technology based on moths and magnets could help treat genetic diseases
November 14, 2018 - Concussion-Related Biomarkers Vary Based on Sex, Race
November 14, 2018 - One more year of high school may shape waistlines later in life
November 14, 2018 - Dissecting high drug costs – Scope
November 14, 2018 - Study shows novel strategy to reduce breast cancer bone metastasis
November 14, 2018 - Empowering the NHS through Industry Partnerships
November 14, 2018 - One size does not fit all in obesity treatment, study finds
November 14, 2018 - Seeking ways to prevent ‘secondary cataracts’
November 14, 2018 - Change Within the Eye May Be Early Warning for Macular Degeneration
November 14, 2018 - Study of 500,000 people clarifies the risks of obesity
November 14, 2018 - Ultrasound releases drug to alter activity in targeted brain areas in rats | News Center
November 14, 2018 - Umass Amherst researchers battle against youth suicide in rural Alaska Native communities
November 14, 2018 - Cancer stem cells depend on amino acid metabolism, and it’s proving to be their Achilles’ heel
November 14, 2018 - Epigenetic link found between prenatal exposure to maternal smoking and offspring’s cardio-metabolic health
November 14, 2018 - Meditation, music may change biomarkers of cellular aging and Alzheimer’s disease in older adults
November 14, 2018 - Multidisciplinaryresearch teams selected to study age-related brain disorders
November 14, 2018 - The Current issue of “The view from here” is concerned with Informatics
November 14, 2018 - Researchers identify tool to help transgender women have a more authentic voice
November 14, 2018 - Four faculty members appointed to endowed professorships | News Center
November 13, 2018 - Research finds strongest evidence yet that obesity causes depression
November 13, 2018 - Researchers compare stools of breastfed and formula-fed infants
November 13, 2018 - Entasis Therapeutics Announces Zoliflodacin Phase 2 Results Published in The New England Journal of Medicine
November 13, 2018 - Gene changes driving myopia reveal new focus for drug development
November 13, 2018 - $6 million grant to support study of preeclampsia, atherosclerosis links | News Center
November 13, 2018 - Beneficial gut microbes metabolize high-fiber diet to improve heart health in mouse model
November 13, 2018 - Excessive use of social media through visual postings linked to increase in narcissistic traits
November 13, 2018 - Study finds why obesity both fuels cancer growth and helps immunotherapy to kill tumors
November 13, 2018 - Women prefer and invest more in daughters, while men favor sons
November 13, 2018 - With hospitalization losing favor, judges order outpatient mental health treatment
November 13, 2018 - Transgenic rat model may provide new insights into cerebral amyloid angiopathy
November 13, 2018 - Study identifies factors tied to greater risk of advanced liver disease in cystic fibrosis patients
November 13, 2018 - Risk of blindness among premature babies with low levels of blood platelets
November 13, 2018 - A new strategy for combatting antibiotic-resistant infections
November 13, 2018 - Study aims to find which outreach method is more effective at improving cancer screening rates
November 13, 2018 - Insufficient sleep duration linked with unhealthy lifestyle profile among children
November 13, 2018 - IIASA researchers introduce new, simple measure for human wellbeing
November 13, 2018 - Magnetic nanosprings used as targeted drug delivery agents for anticancer therapy
November 13, 2018 - Scientists examine FCMs containing silver nanoparticles
November 13, 2018 - Failed DNA repair triggers chromosomal chaos
November 13, 2018 - Study shows new emerging role of osteopontin in HCV-related hepatocellular carcinoma
November 13, 2018 - Food insecurity during pregnancy linked to severity of neonatal abstinence syndrome
November 13, 2018 - Majority of Americans are concerned about health threat posed by antibiotic resistance
November 13, 2018 - Addition of Elotuzumab Ups PFS in Refractory Multiple Myeloma
November 13, 2018 - Study finds women with pregnancy-related nausea, vomiting use marijuana more
November 13, 2018 - Lethal heart rhythm more likely to be found in patients with common heart failure
November 13, 2018 - Study provides new clues to origin and development of multiple sclerosis
November 13, 2018 - Climate change could pose threat to male fertility
November 13, 2018 - Researchers discover how mitochondria deploy a powerful punch against disease-causing bacteria
November 13, 2018 - AHA: Traumatic Childhood Could Increase Heart Disease Risk in Adulthood
November 13, 2018 - Feeling the Burn? | NIH News in Health
November 13, 2018 - Women’s birth canals in Kenya, Korea, Kansas not the same: study
November 13, 2018 - Fecal microbiota transplantation effective against ICI-associated colitis
November 13, 2018 - New physical activity guidelines released that urge people to “move more”
November 13, 2018 - Angiotensin receptor blockers improve sodium excretion in blacks
November 13, 2018 - New project seeks to address alarming injury rate in youth footballers
November 13, 2018 - Fish oil or omega 3 fatty acid supplements can prevent heart attacks finds study
November 13, 2018 - The Human Heart-in-a-Jar That Could One Day Replace Animal Testing
November 13, 2018 - Treat patients’ partners without a doctor visit
November 13, 2018 - Belgian beer landscape mapped using scientific insights
November 13, 2018 - ‘Master key’ gene has links to both ASD and schizophrenia
November 13, 2018 - Gladstone scientists gain new insights into the aging brain
November 13, 2018 - Drug therapy can improve outcomes for acutely ill heart patients
November 13, 2018 - Three landmark studies provide better understanding of sudden cardiac arrest
November 13, 2018 - Cholesterol control revised in the latest AHA/ACC guidelines
Researchers receive $1.2 million grant to test potential treatment for metastatic breast cancer

Researchers receive $1.2 million grant to test potential treatment for metastatic breast cancer

image_pdfDownload PDFimage_print

A team of Medical University of South Carolina (MUSC) Hollings Cancer Center researchers received a three-year, $1.2 million grant from the U.S. Department of Defense (DOD) to test a potential therapeutic antibody that could block breast cancer growth with fewer side effects, opening up potential for future drug development. The team will deploy innovative molecular imaging tools to study a crucial mechanism that appears to drive tumor development.

The study aims to find better ways to treat metastatic breast cancer that could replace current therapies, some of which have life-threatening side effects. Core to the work is Hollings Cancer Center researcher Nancy DeMore, M.D., a leading expert in angiogenesis and therapeutics created for breast cancer.

Angiogenesis, a key phase in malignant growth, involves how blood vessels form, develop and create a network to perfuse different types of solid tumors. Tumors need a blood supply to receive their nutrients and also as an escape route to metastasize to other organs, explains Ann-Marie Broome, Ph.D., director of HCC’s Small Animal Imaging Center, who’s also involved with the study and part of MUSC’s Department of Cell and Molecular Pharmacology & Experimental Therapeutics.

“We have a great team assembled to study this. The power of molecular imaging is clear. We believe that if you can see it, you can dissect its mechanism of action then treat it and attack it. That’s the greatest impact I see for translational imaging studies. That’s why I’m excited.”

Traditional chemotherapeutic drugs kill rapidly dividing cancer cells, but they can also destroy or damage many healthy cells. Developing less toxic interventions requires changing the target from rapidly-dividing cells to one that is specifically expressed in tumors and not in normal tissue.

DeMore’s laboratory is studying the role a novel angiogenesis factor, a protein known as secreted-frizzled-related protein 2 (SFRP2), plays in breast cancer. “The SFRP2 protein is overexpressed in tumor vessels, and later we found that it was overexpressed in a wide variety of tumors, including breast cancer,” said DeMore, who holds the BMW Endowed Chair in Cancer Research at MUSC.

The thought is to inhibit reactions downstream from SFRP2, selectively blocking tumor blood vessels from growing and reducing toxicity to normal tissue.

In preclinical studies, DeMore’s laboratory discovered that a SFRP2 protein has a novel function. The protein activates a mechanism called calcineurin/NFAT, which is critical in blood vessel and tumor growth.

Now the Hollings Cancer Center team seeks to test whether the calcineurin/NFAT mechanism, rather than other potential mechanisms, is driving breast tumor growth, and whether tumor development can be blocked by targeting this pathway. The researchers have developed a novel humanized antibody that has already proved effective in blocking the calcineurin/NFAT pathway and tumor development in cultured human cell models of breast cancer.

“We hope to find out whether our antibody inhibits tumor growth through the calcineurin/NFAT pathway instead of other pathways,” DeMore said.

The researchers plan to study the humanized antibody in an animal model to learn whether it disrupts the calcineurin/NFAT mechanism, preventing in vivo tumor growth while leaving normal tissue unaffected. Broome said the antibody recognizes a protein found on blood vessels.

“By impacting angiogenesis and blood vessel stability within tumors, we can alter the way these tumors are able to survive in the presence of that antibody. We’re creating a fine balance between cutting off the nutrients and normalizing the vasculature so that the tumors are less likely to progress.”

The researchers will use real-time fluorescence imaging systems to highlight and reveal interactions among protein pathways within tumors that have not been seen using other methods. “The fluorescent systems, which are one of the most sensitive imaging tools available, give us faster, clearer images and more specific answers to the questions that we are asking,” Broome said. “It’s not enough just to know that there is a therapeutic response to the antibody. We want to know why and where there is a response.”

The researchers will corroborate fluorescence imaging findings with other modalities, such as computed tomography (CT) images and bioluminescence tools. Tracking SFRP2 pathways with innovative imaging tools could eventually help clinicians track tumor growth and monitor response to chemotherapy. Another aim of the study is to combine the humanized antibody with other drugs commonly used for breast cancer and look for an additive or synergistic effect.

The DOD grant also supports a related study by Shikhar Mehrotra, Ph.D., investigating whether SFRP2 may also play an important role in immune cell function.

A potential treatment is not yet available for human studies, but the team plans to obtain funding for further drug development that could lead to a Phase I clinical trial.

Source:

http://academicdepartments.musc.edu/newscenter/2018/hcc-metastatic-breast-cancer/index.html

Tagged with:

About author

Related Articles